Brief: Arca Biopharma Announces Third Quarter 2022 Financial Results
28/10/2022 21:32
Oct 28 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
* ARCA BIOPHARMA INC Q3 LOSS PER SHARE $0.16
* ARCA BIOPHARMA INC - BELIEVES CURRENT CASH, CASH
EQUIVALENTS,
WILL BE SUFFICIENT TO FUND OPERATIONS AT CURRENT LEVELS THROUGH
AT LEAST END OF 2023
Source text for Eikon: ID:nGNX3c9LsR
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary